It seems pretty evident to me that the street does not believe the company at this point and in fact believes they are "data mining" their drisapersen results, as every comment they make is met with immediate selling. That leads me to think that unless we get a resubmittal of data to FDA for approval or some of their other trial results come through...this thing is stuck.
I would like to think that the large bids that were in place most of the day between $6.02-$6.08 are in fact, just the opposite...they are shorts finally covering their positions. EDGX is the market maker who always sits on the ASK pushing this down, so the fact they were on the bid large most of the day would seem to imply covering. Whether that is true or not, I have no idea. All of this is JMHO, of course.
Recent RNA News
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/21/2024 08:05:00 PM
- Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day • PR Newswire (US) • 06/20/2024 01:00:00 PM
- Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 06/17/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:06:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:58:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:56:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:58:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/14/2024 08:10:22 PM
- Avidity Biosciences to Participate in Upcoming Investor Conference • PR Newswire (US) • 06/14/2024 01:00:00 PM
- Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock • PR Newswire (US) • 06/14/2024 12:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/13/2024 08:26:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/12/2024 08:22:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/12/2024 08:19:05 PM
- Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock • PR Newswire (US) • 06/12/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 11:02:29 AM
- Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes and Trends of Functional Improvement in People Living with Facioscapulohumeral Muscular Dystrophy • PR Newswire (US) • 06/12/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:46:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:27:15 PM
- Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in People Living with Facioscapulohumeral Muscular Dystrophy at 31st Annual FSHD Society International Research Congress • PR Newswire (US) • 05/29/2024 08:05:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/21/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 10:21:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 10:15:29 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/15/2024 01:10:57 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM